Clinical TrialID 408

BDNF Levels After Bacopa

NCT03974399

Memory

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
408
Evidence Id
408
Core Evidence Id
408
Source Clinical Trial Id
395
Herb2 Clinical Trial Id
HBCT000395
Nct Id
NCT03974399
Title
BDNF Levels After Bacopa
Status
Completed
Phase
Study Result
No
Study Condition
Memory
Study Type
Interventional
Study Design
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Intervention
DIETARY_SUPPLEMENT: Bacopa Monnieri
Intervention Allocation
Intervention Model
Single_Group
Intervention Mask
Intervention Purpose
Basic_Science
Gender
All
Age
Adult, Older_Adult
Enrollment
44
Outcome Measure
Changes in Brain Derived neurotrophic factor (BDNF), a. Change in BDNF levels, 3 months|Changes in Brain Derived Neurotropic factor (BDNF) signaling pathway, Change in BDNF signaling pathway, 3 months
Sponsor Collaborator
Roskamp Institute Inc.|Florida Department of Health
Funded By
OTHER
Location
The Roskamp Institute, Inc., Sarasota, Florida, 34243, United States
Other Id
RI-Bacopa-001
Start Date
2019-05-30
Primary Completion Date
2020-04-01
Completion Date
2020-06-01
First Posted
2019-06-04
Results First Posted
Last Update Posted
2021-03-02
Study Document
Study Url
https://clinicaltrials.gov/study/NCT03974399
Title Cn
Title En
BDNF Levels After Bacopa
Bilingual Status
semi_complete